Boston Scientific (BSX) PT Raised to $28 at Needham & Company
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street closes lower as oil prices jump, indexes notch monthly gains
- The Warsh pivot markets didn't expect
- Oil settles up by more than 2.5% as US and Iran resume military attacks
- Energy stocks rally as fresh U.S.-Iran attacks drive oil prices higher
- BofA turns S&P 500 signals from red to yellow: What to buy now
Wedbush Raises Price Target on Boston Scientific (BSX) to $25 Following 2Q
July 29, 2016 8:14 AM EDTWedbush reiterated a Neutral rating on Boston Scientific (NYSE: BSX), and raised the price target to $25.00 (from $23.00), following the company's 2Q earnings report. Total sales were $2.126 billion, and $80 million ahead of consensus, while adjusted EPS of $0.27 was in line.
Analyst Tao Levy... More
Boston Scientific (BSX) PT Bumped to $26 at Evercore ISI
July 28, 2016 12:46 PM EDTEvercore ISI analyst Vijay Kumar reiterated a Buy rating and lifted his price target on Boston Scientific (NYSE: BSX) to $26.00 (from $25.50) following results this morning.
The firm maintained FY 2016 EPS of $1.11, FY 2017 EPS of $1.30 and raised FY 2018 EPS from $1.52 to $1.55.
Kumar commented, "Just when investors sighed a breath of relief after last Q when the long awaited new product momentum drove a... More
Boston Scientific (BSX) Reports In-Line Q2 EPS; Bumps FY16 Rev View
July 28, 2016 6:34 AM EDTBoston Scientific (NYSE: BSX) reported Q2 EPS of $0.27, in-line with the analyst estimate of $0.27. Revenue for the quarter came in at $2.13 billion versus the consensus estimate of $2.05 billion.
"Our strong performance is evidence of the success of our category leadership strategy," said Mike... More
